{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:22:22Z","timestamp":1777476142152,"version":"3.51.4"},"reference-count":57,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.3892\/ol.2016.5101","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T11:52:25Z","timestamp":1473249145000},"page":"3296-3304","source":"Crossref","is-referenced-by-count":12,"title":["Quantitative label-free mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue representing the invasive cutaneous malignant melanoma proteome"],"prefix":"10.3892","volume":"12","author":[{"given":"Paul","family":"Dowling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benvon","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edel","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Meleady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Clynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mairin","family":"McMenamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Monks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bairbre","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Ormond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"key20180108111236_b1-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1200\/JCO.2014.59.9746","article-title":"Clinical cancer advances 2015: Annual report on progress against cancer from the American society of clinical oncology","volume":"33","author":"Masters","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20180108111236_b2-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180108111236_b3-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180108111236_b4-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1586\/era.11.25","article-title":"Therapy for metastatic melanoma: An overview and update","volume":"11","author":"Boyle","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20180108111236_b5-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"177","DOI":"10.14694\/EdBook_AM.2015.35.177","article-title":"Achievements and challenges of molecular targeted therapy in melanoma","volume":"2015","author":"Sullivan","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"key20180108111236_b6-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.metabol.2014.10.027","article-title":"Biomarkers for personalized oncology: Recent advances and future challenges","volume":"64","author":"Kalia","year":"2015","journal-title":"Metabolism"},{"key":"key20180108111236_b7-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.soc.2014.12.011","article-title":"Targeted therapies in melanoma","volume":"24","author":"Moschos","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"key20180108111236_b8-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/bmc.3157","article-title":"Recent advances in proteomics: Towards the human proteome","volume":"28","author":"Wang","year":"2014","journal-title":"Biomed Chromatogr"},{"key":"key20180108111236_b9-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.clinbiochem.2012.12.011","article-title":"The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma","volume":"46","author":"Bougnoux","year":"2013","journal-title":"Clin Biochem"},{"key":"key20180108111236_b10-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4172\/jpb.1000260","article-title":"Quantitative proteomics identifies activation of hallmark pathways of cancer in patient melanoma","volume":"6","author":"Byrum","year":"2013","journal-title":"J Proteomics Bioinform"},{"key":"key20180108111236_b11-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.bbamem.2014.04.004","article-title":"Peptide: lipid ratio and membrane surface charge determine the mechanism of action of the antimicrobial peptide BP100. Conformational and functional studies","volume":"1838","author":"Manzini","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"key20180108111236_b12-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbapap.2014.10.003","article-title":"Proteomic developments in the analysis of formalin-fixed tissue","volume":"1854","author":"Gustafsson","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key20180108111236_b13-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jprot.2014.08.013","article-title":"Comparison of two FFPE preparation methods using label-free shotgun proteomics: Application to tissues of diverticulitis patients","volume":"112","author":"Quesada-Calvo","year":"2015","journal-title":"J Proteomics"},{"key":"key20180108111236_b14-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1559-0275-11-28","article-title":"Critical comparison of sample preparation strategies for shotgun proteomic analysis of formalin-fixed, paraffin-embedded samples: Insights from liver tissue","volume":"11","author":"Tanca","year":"2014","journal-title":"Clin Proteomics"},{"key":"key20180108111236_b15-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1167\/iovs.11-9019","article-title":"Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did not","volume":"53","author":"Linge","year":"2012","journal-title":"Invest Opthalmol Vis Sci"},{"key":"key20180108111236_b16-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1021\/pr100234w","article-title":"Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry","volume":"9","author":"Ostasiewicz","year":"2010","journal-title":"J Proteome Res"},{"key":"key20180108111236_b17-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cca.2014.12.005","article-title":"Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer","volume":"441","author":"Dowling","year":"2015","journal-title":"Clin Chim Acta"},{"key":"key20180108111236_b18-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: Protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key20180108111236_b19-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"e0142650","DOI":"10.1371\/journal.pone.0142650","article-title":"Comparison of different buffers for protein extraction from formalin-fixed and paraffin-embedded tissue specimens","volume":"10","author":"Shen","year":"2015","journal-title":"PLoS One"},{"key":"key20180108111236_b20-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"THE metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol"},{"key":"key20180108111236_b21-ol-0-0-5101","doi-asserted-by":"crossref","DOI":"10.1111\/pcmr.12495","article-title":"Acidic tumor microenvironment in human melanoma","author":"B\u00f6hme","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20180108111236_b22-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4161\/cam.26345","article-title":"How does cancer cell metabolism affect tumor migration and invasion?","volume":"7","author":"Han","year":"2013","journal-title":"Cell Adh Migr"},{"key":"key20180108111236_b23-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13045-015-0117-5","article-title":"Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K\/AKT pathway","volume":"8","author":"Fu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"key20180108111236_b24-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","article-title":"PKM2 contributes to cancer metabolism","volume":"356","author":"Wong","year":"2015","journal-title":"Cancer Lett"},{"key":"key20180108111236_b25-ol-0-0-5101","first-page":"3153","article-title":"Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas","volume":"17","author":"Eigenbrodt","year":"1997","journal-title":"Anticancer Res"},{"key":"key20180108111236_b26-ol-0-0-5101","first-page":"5077","article-title":"Tumor type M2 pyruvate kinase expression in advanced breast cancer","volume":"20","author":"L\u00fcftner","year":"2000","journal-title":"Anticancer Res"},{"key":"key20180108111236_b27-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"e74611","DOI":"10.1371\/journal.pone.0074611","article-title":"Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOP\u039f-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide","volume":"8","author":"Karachaliou","year":"2013","journal-title":"PLoS One"},{"key":"key20180108111236_b28-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.18632\/oncotarget.1159","article-title":"Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers","volume":"5","author":"Desai","year":"2014","journal-title":"Oncotarget"},{"key":"key20180108111236_b29-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/CMR.0000000000000027","article-title":"High expression of glycolytic and pigment proteins is associated with worse clinical outcome in stage III melanoma","volume":"23","author":"Falkenius","year":"2013","journal-title":"Melanoma Res"},{"key":"key20180108111236_b30-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"e101060","DOI":"10.1371\/journal.pone.0101060","article-title":"Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration","volume":"9","author":"Rossato","year":"2014","journal-title":"PLoS One"},{"key":"key20180108111236_b31-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","article-title":"FoxO transcription factors; Regulation by AKT and 14-3-3 proteins","volume":"1813","author":"Tzivion","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key20180108111236_b32-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.yexcr.2013.10.016","article-title":"Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity","volume":"320","author":"Hopperton","year":"2014","journal-title":"Exp Cell Res"},{"key":"key20180108111236_b33-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20180108111236_b34-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ijc.10127","article-title":"Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer","volume":"98","author":"Swinnen","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180108111236_b35-ol-0-0-5101","first-page":"707","article-title":"Fatty acid synthase expression defines distinct molecular signatures in prostate cancer","volume":"1","author":"Rossi","year":"2003","journal-title":"Mol Cancer Res"},{"key":"key20180108111236_b36-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3835(01)00464-5","article-title":"Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients","volume":"167","author":"Wang","year":"2001","journal-title":"Cancer Lett"},{"key":"key20180108111236_b37-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12967-015-0511-3","article-title":"Fatty acid synthase overexpression: Target for therapy and reversal of chemoresistance in ovarian cancer","volume":"13","author":"Bauerschlag","year":"2015","journal-title":"J Transl Med"},{"key":"key20180108111236_b38-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.arcmed.2010.08.007","article-title":"Increased fatty acid synthase activity in non-small cell lung cancer tissue is a weaker predictor of shorter patient survival than increased lipoprotein lipase activity","volume":"41","author":"Cerne","year":"2010","journal-title":"Arch Med Res"},{"key":"key20180108111236_b39-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1600-0560.2003.300104.x","article-title":"Fatty acid synthase expression in melanoma","volume":"30","author":"Innocenzi","year":"2003","journal-title":"J Cutan Pathol"},{"key":"key20180108111236_b40-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/modpathol.3800395","article-title":"Fatty acid synthase expression in cutaneous melanocytic neoplasms","volume":"18","author":"Kapur","year":"2005","journal-title":"Mod Pathol"},{"key":"key20180108111236_b41-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/bjc.2012.355","article-title":"The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas","volume":"107","author":"Seguin","year":"2012","journal-title":"Br J Cancer"},{"key":"key20180108111236_b42-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/fon.10.11","article-title":"Fatty acid synthase as a potential therapeutic target in cancer","volume":"6","author":"Flavin","year":"2010","journal-title":"Future Oncol"},{"key":"key20180108111236_b43-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/excr.2002.5600","article-title":"Activation of fatty acid synthesis during neoplastic transformation: Role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"279","author":"Yang","year":"2002","journal-title":"Exp Cell Res"},{"key":"key20180108111236_b44-ol-0-0-5101","first-page":"642","article-title":"Role of the phosphatidylinositol 3\u2032-kinase\/PTEN\/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells","volume":"62","author":"Van de Sande","year":"2002","journal-title":"Cancer Res"},{"key":"key20180108111236_b45-ol-0-0-5101","first-page":"25420","article-title":"Insulin stimulation of the fatty acid synthase promoter is mediated by the phosphatidylinositol 3-kinase pathway","volume":"273","author":"Wang","year":"1998","journal-title":"Involvement of protein kinase B\/Akt. J Biol Chem"},{"key":"key20180108111236_b46-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/sj.onc.1208463","article-title":"Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells","volume":"24","author":"Wang","year":"2005","journal-title":"Oncogene"},{"key":"key20180108111236_b47-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"e42598","DOI":"10.1371\/journal.pone.0042598","article-title":"BRAFV600E negatively regulates the AKT pathway in melanoma cell lines","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"key20180108111236_b48-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1158\/0008-5472.CAN-04-1399","article-title":"Deregulated Akt3 activity promotes development of malignant melanoma","volume":"64","author":"Stahl","year":"2004","journal-title":"Cancer Res"},{"key":"key20180108111236_b49-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.2741\/1755","article-title":"The RAS\/RAF\/MEK\/ERK and PI3K\/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma","volume":"10","author":"Meier","year":"2005","journal-title":"Front Biosci"},{"key":"key20180108111236_b50-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.bbamcr.2011.03.001","article-title":"Regulation of FoxO transcription factors by acetylation and protein-protein interactions","volume":"1813","author":"Daitoku","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key20180108111236_b51-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.semcdb.2011.08.009","article-title":"14-3-3 proteins: Diverse functions in cell proliferation and cancer progression","volume":"22","author":"Freeman","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"key20180108111236_b52-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semcancer.2006.03.004","article-title":"14-3-3 proteins as potential oncogenes","volume":"16","author":"Tzivion","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"key20180108111236_b53-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/onc.2011.284","article-title":"Overexpression of 14-3-3\u03b6 in cancer cells activates PI3K via binding the p85 regulatory subunit","volume":"31","author":"Neal","year":"2012","journal-title":"Oncogene"},{"key":"key20180108111236_b54-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-4598-8-53","article-title":"14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence","volume":"8","author":"Schultz","year":"2009","journal-title":"Mol Cancer"},{"key":"key20180108111236_b55-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1039\/B907863K","article-title":"Dynamical effects of epigenetic silencing of 14-3-3sigma expression","volume":"6","author":"Vera","year":"2010","journal-title":"Mol Biosyst"},{"key":"key20180108111236_b56-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1871520611313040004","article-title":"Upregulation of focal adhesion kinase by 14-3-3\u03b5 via NF\u03baB activation in hepatocellular carcinoma","volume":"13","author":"Ko","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180108111236_b57-ol-0-0-5101","doi-asserted-by":"crossref","first-page":"33024","DOI":"10.1074\/jbc.M313265200","article-title":"Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase\/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway","volume":"279","author":"Xia","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.5101\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T15:00:12Z","timestamp":1515423612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.5101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,9,7]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.3892\/ol.2016.5101"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.5101","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]}}}